title: Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers.
authors.forename: F
authors.initials: F
authors.lastname: Lionnet
authors.forename: C
authors.initials: C
authors.lastname: Bachmeyer
authors.forename: K
authors.initials: K
authors.lastname: Stankovic
authors.forename: P L
authors.initials: PL
authors.lastname: Tharaux
authors.forename: R
authors.initials: R
authors.lastname: Girot
authors.forename: S
authors.initials: S
authors.lastname: Aractingi
mesh_terms: D000755:Anemia, Sickle Cell / Q000150:complications*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D008875:Middle Aged; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan